Adapting the Scar-in-a-Jar to Skin Fibrosis and Screening Traditional and Contemporary Anti-Fibrotic Therapies
Skin fibrosis still constitutes an unmet clinical need. Although pharmacological strategies are at the forefront of scientific and technological research and innovation, their clinical translation is hindered by the poor predictive capacity of the currently available in vitro fibrosis models. Indeed...
Main Authors: | João Q. Coentro, Ulrike May, Stuart Prince, John Zwaagstra, Olli Ritvos, Tero A.H. Järvinen, Dimitrios I. Zeugolis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2021.756399/full |
Similar Items
-
Macromolecular Crowding as a Tool to Screen Anti-fibrotic Drugs: The Scar-in-a-Jar System Revisited
by: Nataly Puerta Cavanzo, et al.
Published: (2021-01-01) -
Macromolecular crowding in animal component-free, xeno-free and foetal bovine serum media for human bone marrow mesenchymal stromal cell expansion and differentiation
by: Stefanie H. Korntner, et al.
Published: (2023-03-01) -
Macromolecular crowding in human tenocyte and skin fibroblast cultures: A comparative analysis
by: Adrian Djalali-Cuevas, et al.
Published: (2024-04-01) -
Midkine-a Regulates the Formation of a Fibrotic Scar During Zebrafish Heart Regeneration
by: Dimitrios Grivas, et al.
Published: (2021-05-01) -
Fibrotic scar after experimental autoimmune encephalomyelitis inhibits oligodendrocyte differentiation
by: Stephanie L. Yahn, et al.
Published: (2020-02-01)